Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST
Articles
One Institution’s Evidence-Based Approach to Adopting Biosimilars
February 1st 2025A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process that examines clinical data, safety profiles, and cost implications while prioritizing operational efficiency, patient access, and seamless transitions between reference products and biosimilars.
Read More
Latest Updated Articles
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 22nd 2025 | Updated: February 1st 2025
A Look at Human Metapneumovirus — a Respiratory Virus You've Likely Had Without Knowing
Published: January 20th 2025 | Updated: February 1st 2025
Your Guide to 2025: Pharma, Formularies, the Pipeline and More
Published: January 23rd 2025 | Updated: February 1st 2025
A New Era: Menopause Support and Workplace Change
Published: January 6th 2025 | Updated: February 1st 2025
Progress Made for Gastric Cancer with FDA Approval of Tevimbra
